Novel Cardiovascular Risk Factor Prediction of Cardiovascular Events in the (Type 2 Diabetes) FIELD Study and Effects of Fenofibrate

被引：0
|
作者：
Keech, Anthony C.
Alicia, Jenkins
Whiting, Malcolm
Barter, Philip
Sullivan, David R.
Donoghoe, Mark
Januszewski, Andrej
Karschimkus, Connie
Blankenberg, Stefan
Simes, John
Scott, Russell
Laakso, Markku
Taskinen, Marja-Riitta
Best, James D.
机构：
[1] Univ Sydney, Sydney, NSW 2006, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Flinders Univ S Australia, Adelaide, SA 5001, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Johannes Gutenberg Univ Mainz, Mainz, Germany
[6] Christchurch Hosp, Christchurch, New Zealand
[7] Univ Kuopio, FIN-70211 Kuopio, Finland
[8] Helsinki Univ Hosp, Helsinki, Finland
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Biomarkers; Risk factors; Cardiovascular disease; Type; 2; Diabetes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18865
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    Tonkin, Andrew
    Hunt, David
    Voysey, Merryn
    Kesaniemi, Antero
    Hamer, Andrew
    Waites, Jonathon
    Mahar, Leo
    Mann, Stewart
    Glasziou, Paul
    Forder, Peta
    Simes, John
    Keech, Anthony C.
    AMERICAN HEART JOURNAL, 2012, 163 (03) : 508 - 514
  • [2] Effect of Fenofibrate on Cardiovascular Events and Mortality in Women with Type 2 Diabetes: Results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    D'Emden, Michael
    Li, Ping Li
    Zannino, Diana
    Best, James
    Keech, Anthony C.
    DIABETES, 2009, 58 : A178 - A178
  • [3] What is the effect of fenofibrate on cardiovascular disease events in patients with type 2 diabetes?
    Theodore Mazzone
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 366 - 367
  • [4] What is the effect of fenofibrate on cardiovascular disease events in patients with type 2 diabetes?
    Mazzone, T.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (07): : 366 - 367
  • [5] Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study
    Ong, Kwok Leung
    O'Connell, Rachel L.
    Januszewski, Andrzej S.
    Donoghoe, Mark W.
    Gebski, Val
    Sullivan, David
    Rye, Kerry Ann
    Scott, Russell S.
    Best, James D.
    Taskinen, Marja-Riitta
    Simes, Robert J.
    Jenkins, Alicia
    Keech, Anthony C.
    DIABETES, 2023, 72
  • [6] Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus
    Song, Do Kyeong
    Hong, Young Sun
    Sung, Yeon-Ah
    Lee, Hyejin
    PLOS ONE, 2024, 19 (02):
  • [7] Effects of long-term fenofibrate therapy on cardiovascular events in people with type 2 diabetes mellitus
    Charles A. Reasner
    Current Atherosclerosis Reports, 2006, 8 (4) : 261 - 262
  • [8] Fibroblast Growth Factor 21 and Cardiovascular Outcome Events in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    Ong, Kwok Leung
    Januszewski, Andrzej S.
    O'Connell, Rachel
    Jenkins, Alicia J.
    Xu, Aimin
    Sullivan, David R.
    Barter, Philip J.
    Hung, Wei Ting
    Keech, Anthony C.
    Rye, Kerry-Anne
    DIABETES, 2014, 63 : A295 - A295
  • [9] Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    Michael C. d’Emden
    Alicia J. Jenkins
    Liping Li
    Diana Zannino
    Kristy P. Mann
    James D. Best
    Bronwyn G. A. Stuckey
    Kris Park
    Juha Saltevo
    Anthony C. Keech
    Diabetologia, 2014, 57 : 2296 - 2303
  • [10] Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    d'Emden, Michael C.
    Jenkins, Alicia J.
    Li, Liping
    Zannino, Diana
    Mann, Kristy P.
    Best, James D.
    Stuckey, Bronwyn G. A.
    Park, Kris
    Saltevo, Juha
    Keech, Anthony C.
    DIABETOLOGIA, 2014, 57 (11) : 2296 - 2303
12345